Hanh Nguyen

Title: Hanh Nguyen: Innovator in Monoclonal Antibody Research

Introduction

Hanh Nguyen is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of humanized monoclonal antibodies. With a total of 2 patents, his work has the potential to impact therapeutic approaches for various diseases.

Latest Patents

Hanh Nguyen's latest patents include groundbreaking research on humanized monoclonal antibodies against human interleukin-4. His patents detail the cloning and expression of these antibodies, which are specific for human interleukin-4. Additionally, he has developed complementary DNAs that encode the heavy and light chain variable regions of such monoclonal antibodies. These innovations also encompass kits and methods for detecting, measuring, and immunopurifying human interleukin-4, as well as techniques for blocking its biological activity.

Career Highlights

Hanh Nguyen is currently employed at Schering Corporation, where he continues to advance his research in monoclonal antibodies. His work is pivotal in the ongoing quest to develop effective treatments for conditions influenced by interleukin-4.

Collaborations

Hanh has collaborated with several talented individuals in his field, including Barbara Dalie and Hung V Le. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Hanh Nguyen's contributions to monoclonal antibody research exemplify the importance of innovation in biotechnology. His patents and ongoing work at Schering Corporation highlight his commitment to advancing medical science.